NCT04379648

Brief Summary

More than 70% of ambulatory patients with IDD have attempted suicide (APA, 2015). This disorder, as well as all the disorders on the dissociation spectrum, must therefore be clarified and better diagnosed. The goal of this research is :

  1. 1.to assess the prevalence of dissociative disorders using specific tools in patients suffering from PTSD.
  2. 2.to validate the French version of the DDIS interview (Ross, 1997) that the investigators have translated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 5, 2019

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 29, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 7, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2021

Completed
Last Updated

May 7, 2020

Status Verified

May 1, 2020

Enrollment Period

1.6 years

First QC Date

April 29, 2020

Last Update Submit

May 6, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post Traumatic Stress

    assessment of the prevalence of dissociative disorders in a cohort of patients with PTSD

    1 year

Study Arms (1)

Posttraumatic stress disorder

OTHER

cohort of patients with Posttraumatic stress disorder PTSD

Other: self-assessment and hetero-assessment

Interventions

Self assessment for the passing of the following rating scales CTQ-SF36-ITQ-PCL5-DES Hetero-assessment for the pasing of the following rating scales DDIS FR and medical interview

Posttraumatic stress disorder

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient diagnosed with PTSD according to DSM 5 criteria
  • Over 18 years of age
  • Informed consent signed

You may not qualify if:

  • Neurological disorders
  • Serious and/or unstable somatic pathologies
  • Patient not affiliated with social security
  • Patient hospitalized under restraint in psychiatric care by decision of the state representative or in psychiatric care at the request of a third party
  • Patient under guardianship
  • Patient participating in parallel in another biomedical research
  • Change of antidepressant in the last three months
  • Patient not mastering the French language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Youcef BENCHERIF

Neuilly-sur-Marne, Île-de-France Region, 93330, France

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Diagnostic Self Evaluation

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Khalid KALALOU, Psychiatrist

    EPS Ville Evrard

    PRINCIPAL INVESTIGATOR

Central Study Contacts

BENCHERIF Youcef, CRA

CONTACT

Rusheenthira THAVASEELAN, CRA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: All patients with a diagnosis of Post Traumatic Stress Disorder will be seen by a physician psychiatrist or psychologist who will introduce them to the study. They will be given an information letter and a consent form. If patients agree to participate in the study, and after signing the consent form, they will be included and will complete the assessment scales.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical research unit manager

Study Record Dates

First Submitted

April 29, 2020

First Posted

May 7, 2020

Study Start

February 5, 2019

Primary Completion

September 5, 2020

Study Completion

September 5, 2021

Last Updated

May 7, 2020

Record last verified: 2020-05

Locations